A chitosan-containing curcumin sustained-release aggregate and preparation method thereof
A technology of curcumin and chitosan, which is applied in the directions of inactive medical preparations, pharmaceutical formulations, antibacterial drugs, etc., can solve the problems of unfavorable curcumin slow release, poor stability, poor curcumin slow release effect, etc. Achieve stable liquid crystal structure, reduce waste, and achieve the effect of targeted release
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Weigh 1.98g of Tween 80 and 0.275g of ethyl oleate and place them in a clean 10mL colorimetric tube, then weigh 0.0075g of curcumin and place them in the mixture of Tween 80 and ethyl oleate, put them in a magnetic Use a magnetic stirrer to stir for 2.5 hours, and control the temperature of the water bath to 25°C to ensure that the curcumin is fully dissolved in the mixture of the surfactant and the oil phase. Then add 0.495g of water-soluble chitosan and 2.25g of water, use a quick mixer to mix evenly, control the temperature at 60°C, and centrifugally stir until the sample is completely dissolved, and use a centrifuge to keep the speed at 3500r / min to remove air bubbles in the sample , so as to obtain curcumin sustained-release drug-loaded aggregates containing chitosan, denoted as E 2 C 3 .
[0054] In this embodiment, the mass ratio of Tween 80, water-soluble chitosan, ethyl oleate and water is 39.6:9.9:5.5:45.
Embodiment 2
[0056] This embodiment is the same as Example 1, except that the mass ratio of Tween 80, water-soluble chitosan, ethyl oleate and water in this embodiment is 47.0:5.2:2.8:45, and the prepared shell-containing Curcumin slow-release drug-loaded aggregates of glycans, denoted as E 1 C 1 .
Embodiment 3
[0058] This embodiment is the same as Example 1, except that the mass ratio of Tween 80, water-soluble chitosan, ethyl oleate and water in this embodiment is 44.5:5.0:5.5:45, and the prepared shell-containing Curcumin slow-release drug-loaded aggregates of glycans, denoted as E 2 C 1 .
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com